Clinical Trials Directory

Trials / Completed

CompletedNCT01430520

Analgesic Effect of Escitalopram in Total Knee Arthroplasty (TKA)

Analgesic Effect of Perioperative Escitalopram for Patients With High Preoperative Level of Pain Catastrophising in Total Knee Arthroplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Pain is a major problem after TKA, especially in patients with high pain catastrophizing. Newer MR-scan studies indicate that Escitalopram may have an immediate cognitive and emotional effect. The investigators therefore investigate the effect of Escitalopram as a perioperative analgesic.

Detailed description

Pain is a major problem after TKA, especially in patients with high pain catastrophizing. Newer MR-scan studies indicate that Escitalopram may have an immediate cognitive and emotional effect. Patients with high pain catastrophizing are mentally vulnerable and may be sensitive to the effects of Escitalopram. We therefore investigate the effect of Escitalopram as a perioperative analgesic in this group of patients where the pain problem is pronounced.

Conditions

Interventions

TypeNameDescription
DRUGEscitalopramTables with Escitalopram (10 mg), 1 tablet a day for 7 days, starting on the day of surgery
DRUGPlaceboPlacebo tablets, 1 tablet a day for 7 days, starting on the day of surgery

Timeline

Start date
2011-09-01
Primary completion
2013-04-01
Completion
2013-05-01
First posted
2011-09-08
Last updated
2013-06-05

Locations

3 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01430520. Inclusion in this directory is not an endorsement.